While the Omnipod System does not come with a CGM (which would allow you to make real-time adjustments), some diabetes management companies are working on bringing CGM data to the Omnipod System
Effects of liraglutide on heart rate and heart rate variability: a randomized, double-blind, placebo-controlled crossover study
After almost two decades of the clinical use of GLP-1 for T2D and 10 years after the first GLP-1 medicine, liraglutide, was approved for #weight loss in people with obesity, the next decade may bring even greater progress, introducing more powerful GLP-1 medicines while expanding the utility of GLP-1 therapeutics beyond currently established #cardiometabolic disorders #GLP #obesity #publichealth #medicines #pharmacology Jean-Michel Dogns Post The benefits of GLP-1 drugs beyond obesity Excellent review on the Glucagon-like peptide1based medicines #diabetes and weight lossindependent actions
10.1210/jendso/bvz042 38 IbrahimN
Storage: Store in a cool, dry place.
Patients should bring their monitoring records to these appointments to facilitate informed discussions about treatment optimisation
